Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience

INTRODUCTION: Anti-vascular endothelial growth factor (VEGF) therapy is the first-line treatment for diabetic macular edema (DME). We investigated the effect of initial glycosylated hemoglobin (HbA1c) level and glomerular filtration rate (GFR) on treatment outcomes in patients with DME receiving ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Debourdeau, Eloi, Medard, Robin, Chamard, Chloe, Nguyen, Vuong, Gabrielle, Pierre Henry, Creuzot-Garcher, Catherine, Allieu, Sandrine, Gillies, Mark C., Barthelmes, Daniel, Daien, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441844/
https://www.ncbi.nlm.nih.gov/pubmed/37505396
http://dx.doi.org/10.1007/s40123-023-00758-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441844/
https://www.ncbi.nlm.nih.gov/pubmed/37505396
http://dx.doi.org/10.1007/s40123-023-00758-1

Ejemplares similares